Archive
API

Local Coverage Determination (LCD)

Removal of Benign Skin Lesions

L34938

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L34938
Original ICD-9 LCD ID
Not Applicable
LCD Title
Removal of Benign Skin Lesions
Proposed LCD in Comment Period
N/A
Source Proposed LCD
DL34938
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 09/26/2019
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
12/08/2016
Notice Period End Date
01/31/2017

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

This LCD supplements but does not replace, modify, or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for benign skin lesion services. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify, or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions and/or scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations and rules for Medicare payment for removal of benign skin lesion services and must properly submit only valid claims for them. Please review and understand them and apply the medical necessity provisions in the policy within the context of the manual rules. Relevant CMS manual instructions and policies may be found in the following Internet-Only Manuals (IOMs) published on the CMS Web site.

IOM Citations:

  • CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 16, Section 120: Cosmetic Surgery.
  • CMS IOM Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, Section 250.4: Treatment of Actinic Keratosis.
  • CMS IOM Publication 100-04, Medicare Claims Processing Manual, Chapter 12, Section 30.6: Evaluation and Management Codes - General, Section 40.1: Definition of a Global Surgical Package, Section 40.2: Billing Requirements for Global Surgeries, Section 40.3: Claims Review for Global Surgeries.
  • CMS IOM Publication 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.4 Reasonable and Necessary Provision in an LCD.


Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.
  • Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.
  • Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.
  • Title XVIII of the Social Security Act, Section 1862 (a)(10). This section excludes Cosmetic Surgery.
  • Title XVIII of the Social Security Act, Section 1865 states effects of accreditation.

 

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Notice: Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Benign lesions may be removed in a variety of ways. These methods can be grouped into one of the following three categories.

  1. Shaving of Epidermal or Dermal Lesions
    • Shaving is the sharp removal by transverse incision or horizontal slicing to remove epidermal and dermal lesions without a full-thickness dermal excision. This includes local anesthesia, chemical or electrocauterization. The wound does not require suture closure.
  2. Excision - Benign Lesions
    • Excision of benign lesions of skin includes local anesthesia. Excision is defined as full-thickness (through the dermis) removal of a lesion, including margins, and includes simple (non-layered) closure when performed.
  3. Destruction, Benign Lesions
    • Destruction means the ablation of benign tissues by any method, with or without curettement, including local anesthesia, and not usually requiring closure.
    • Medical record documentation must support medical necessity for excisional removal of a benign skin lesion for other than cosmetic purposes. Each benign lesion excised should be reported separately.

Covered Indications

In selected circumstances, the removal of lesions (e.g., seborrheic keratoses, epidermoid cysts, moles [nevi], acquired hyperkeratosis, molluscum contagiosum, milia, viral warts, benign neoplasms, hemangiomas, lipomas, and pyogenic granulomas) is medically appropriate. Therefore, Medicare will consider their removal as medically necessary, and not cosmetic, if one or more of the following conditions are present and clearly documented in the medical record:

  1. The lesion has become symptomatic or has undergone a change in appearance or displays evidence of inflammation or infection.
  2. The lesion obstructs an orifice.
  3. The lesion clinically restricts eye function. For example, the lesion
    • restricts eyelid function
    • causes misdirection of eyelashes or eyelid
    • restricts lacrimal puncta and interferes with tear flow
    • touches the globe
    • interferes with vision
  4. There is clinical uncertainty as to the likely diagnosis, particularly where malignancy is a realistic consideration based on lesion appearance or prior biopsy of a related or similar lesion suggesting malignancy.
  5. A prior histological exam or biopsy suggests or is indicative of atypia (e.g., atypical nevus) or malignancy.
  6. The lesion is in an anatomical region subject to recurrent physical trauma and there is documentation that such trauma has occurred.
  7. Removal of molluscum contagiosum.
  8. Benign epidermal or pilar cyst with history of infection, drainage, or rupture.
  9. Wart removals will be covered under guidelines above. In addition, wart destruction will be covered when any of the following clinical circumstances are present:
    • Periocular warts associated with chronic recurrent conjunctivitis thought to be secondary to lesion virus shedding
    • Warts showing evidence of spread from one body area to another
    • Lesions are condyloma acuminate
  10. Please refer to the National Coverage Determination (NCD) 250.4 for coverage details regarding Actinic Keratosis.


Limitations

The following are considered not reasonable and necessary and therefore will be denied:

  1. Please refer to CMS IOM Publication 100-04, Medicare Claims Processing Manual, Chapter 12, Section 30.6.6 for instructions regarding Evaluation and Management (E/M) services during the global period of surgery and on the same day as a procedure.
  2. Removal of certain benign skin lesions that do not pose a threat to health or function is considered cosmetic, and as such, is not covered by the Medicare program. If the beneficiary wishes to have one or more of these benign asymptomatic lesions removed for cosmetic purposes, the beneficiary becomes liable for the service rendered. The provider has the responsibility to notify the patient in advance that Medicare will not cover that cosmetic procedure and the beneficiary will be liable for the cost of the service.
  3. Lesions in sensitive anatomical locations that are not creating problems do not qualify for removal coverage on the basis of location alone.


Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD.
Summary of Evidence

N/A
Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
View Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.
N/A

Revenue Codes

Code Description

Please accept the License to see the codes.
N/A

CPT/HCPCS Codes

Expand All | Collapse All

Please accept the License to see the codes.

N/A

ICD-10-CM Codes that Support Medical Necessity

Expand All | Collapse All

Group 1

Group 1 Paragraph:

N/A

 Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Expand All | Collapse All

Group 1

Group 1 Paragraph:

N/A

 Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information


Refer to the Local Coverage Article: Billing and Coding: Removal of Benign Skin Lesions, A57113, for all coding information.

Documentation Requirements

  1. All documentation must be maintained in the patient’s medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g. complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The medical record documentation must support the medical necessity of the services as stated in this policy.
  4. The type of removal is at the discretion of the treating physician or non-physician practitioner and the appropriateness of the technique used will not be a factor in deciding if the lesion merits removal. Medical record documentation must support that the technique used is appropriate for that lesion removal.
  5. A statement of “irritated skin lesion” or “inflamed seborrheic keratosis” will be insufficient justification for lesion removal when used solely to describe a patient’s complaint or the physician’s or non-physician practitioner’s physical findings. It is important to document the patient’s signs and symptoms as well as the physician’s or non-physician practitioner’s physical findings.
  6. Drawings or diagrams to describe the precise anatomical location of the lesion are helpful. Documentation of a procedural note, protocol describing indications, diagnosis, and method (or modality) of treatment is advised.
  7. The decision to submit a specimen for pathologic interpretation will be independent of the decision to remove or not remove the lesion. It is assumed, however, that a tissue diagnosis will be part of the medical record when an ultimately benign lesion is removed based on physician or non-physician practitioner’s uncertainty as to the final clinical diagnosis.

Utilization Guidelines

In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice.
Sources of Information


Other Contractor’s Policies

Contractor Medical Directors

"Cosmetic and Reconstructive Procedures in Plastic Surgery”, published by the American Society of Plastic and Reconstructive Surgeons, Inc., 1989.

Dermatology consultant expert opinions to Carrier Medical Director Workgroup.
Bibliography
  1. Epstein E. Dermatologic disorders in "The Merck Manual", 16th ED., New Jersey: Merek and Co., Inc., 1992, pp 2399-2460.
  2. Ho V, McLean DI Benign epithelial tumors in “Dermatology in General Medicine”, 4th Ed., McGraw-Hill, Inc., pp 855-872.
  3. Kaushik S, Pepas L, Nordin A, et al. Surgical interventions for high-grade vulval intraepithelial neoplasia (Review), Cochrane Database of Systematic Reviews. 2014, Issue 3, Art. No. CD007928. DOI: 10.1002/14651858.CD007928.pub3.

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
09/26/2019 R10

LCD revised and updated 09/26/2019. Consistent with CMS Change Request 10901, the entire Coding information section has been removed from this LCD. Slight formatting changes were made and language contained in the various CMS manuals has been removed from the body of the policy and replaced with a reference to the applicable manual. Please see the related Billing and Coding Article A57113 for all codes and information related to coding and billing.
  • Other (CMS Change Request 10901)
10/01/2018 R9

LCD revised and published on 10/25/2018 effective for dates of service on and after 10/01/2018 to reflect the ICD-10-CM Annual Code Updates. The following ICD-10-CM code(s) have been deleted and therefore removed from Group 1 and Group 5 Codes of the LCD: D22.11, D22.12, D23.11, D23.12. The following ICD-10-CM code(s) have been added to Group 1 and Group 5 Codes: D22.111, D22.112, D22.121, D22.122, D23.111, D23.112, D23.121, D23.122. Documentation Requirement #2 and #4 updated with standard policy language.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy.
  • Revisions Due To ICD-10-CM Code Changes
  • Other (Clarification)
01/01/2018 R8

LCD revised and published on 01/25/2018 effective for dates of service on and after 01/01/2018 to reflect the annual CPT/HCPCS code updates. For the following CPT/HCPCS code either the short description and/or the long description was changed: 11403. Depending on which description is used in this LCD there may not be any change in how the code displays in the document. Source added that was reviewed and considered; however, the source was inadvertently not listed with the previous LCD revision.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy.
  • Revisions Due To CPT/HCPCS Code Changes
  • Typographical Error
11/09/2017 R7

LCD revised and published on 11/09/2017 effective for dates of service on and after 09/13/2017 to add the following ICD-10 diagnosis codes to Group 7 Codes: D07.1, N90.0, N90.1, and N90.3. LCD revised with effective dates of service on and after 10/01/2017 to reflect the 4Q17 CPT/HCPCS code updates. For the following CPT/HCPCS code(s) either the short description and/or the long description was changed: 11403. Depending on which description is used in this LCD, there may not be any change in how the code displays in the document.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy.
  • Revisions Due To CPT/HCPCS Code Changes
  • Reconsideration Request
02/01/2017 R6

LCD revised and published on 07/13/2017 effective for dates of service on and after 02/01/2017 to add the following ICD-10 diagnosis codes to Group 3 and Group 4: D22.5, D22.61, D22.62, D22.71 and D22.72.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy
  • Other (Inquiry)
02/01/2017 R5

LCD revised and published on 06/08/2017 effective for dates of service on and after 02/01/2017 to add the following ICD-10 diagnosis codes to the Group 1 diagnosis code list: L29.9. L56.5, R20.8, R23.3, R23.8, R52, and R58; to the Group 2 diagnosis code list: D22.5, D22.61, D22.62, D22.71, D22.72, L29.9, R20.8, R23.3, R23.8, R52, and R58; to the Group 3 diagnosis code list: D22.4, D49.59, L29.9, R20.8, R23.3, R23.8, R52, and R58; to the Group 4 diagnosis code list: D22.4, D49.59, L29.9, R20.8, R23.3, R23.8, R52, and R58; to the Group 5 diagnosis code list: D18.1, D22.0, D22.11, D22.12, D22.21, D22.22, D22.39, D22.4, D22.5, D22.61, D22.62, D22.71, D22.72, D49.59, L29.9, R20.8, R23.3, R23.8, R52, and R58; to the Group 6 diagnosis code list: D49.59; and to the Group 7 diagnosis code list: D49.2 and D49.59.
  • Other (Inquiry
    )
02/01/2017 R4 LCD revised and published on 04/13/2017 effective for dates of service on and after 01/01/2017 to reflect the first quarter 2017 CPT/HCPCS code updates. For the following CPT code either the short description and/or the long description was changed. Depending on which description is used in this LCD, there may not be any change in how the code displays in the document: 11403.
  • Revisions Due To CPT/HCPCS Code Changes
02/01/2017 R3 LCD posted for notice on 12/08/2016. LCD becomes effective for dates of service on and after 02/01/2017.

03/03/2016 DL34938 Draft LCD posted for comment.
  • Aberrant Local Utilization
10/01/2016 R2 LCD revised and published on 09/29/2016 effective for dates of service on and after 10/01/2016 to reflect the ICD-10 Annual Code Updates. The following ICD-10 code has been deleted and therefore removed from the Group 1 diagnosis code list of the LCD: D49.5. ICD-10 code D49.59 has been added to the Group 1 diagnosis code list.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R1 LCD revised and published on 03/10/2016 effective for dates of service on or after 10/01/2015 to add the following ICD-10 code to Group 1: D17.0.
  • Reconsideration Request
N/A

Associated Documents

Attachments
N/A
Related Local Coverage Documents
Articles
A57113 - Billing and Coding: Removal of Benign Skin Lesions
Related National Coverage Documents
NCDs
250.4 - Treatment of Actinic Keratosis
Public Versions
Updated On Effective Dates Status
09/20/2019 09/26/2019 - N/A Currently in Effect You are here
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer

Submit Feedback/Ask a Question